Tamarando to skip Breeders' Cup due to Lasix ban

ARCADIA, Calif. – Tamarando, the winner of the Grade 1 Del Mar Futurity on Sept. 4, will not run in the $2 million Breeders’ Cup Juvenile at Santa Anita on Nov. 2 but will start in the $200,000 Golden State Juvenile on Nov. 1, trainer Jerry Hollendorfer said.

Hollendorfer said the decision is based on the Breeders’ Cup’s policy of banning the use of the anti-bleeder medication Lasix in the BC Juvenile and other 2-year-old races Nov. 1-2.

“We can’t use Lasix and don’t want to chance him bleeding in that race and sacrificing some of his career,” Hollendorfer said.

The decision was made Friday after Hollendorfer consulted with Larry Williams, who co-owns Tamarando with his wife, Marianne.

“Larry asked me to make the decision, and that’s the decision I made,” Hollendorfer said.

[BREEDERS’ CUP 2013: See DRF’s top contenders]

Tamarando, bred by the Williamses, was not nominated to the Breeders’ Cup program as a weanling. To start in the BC Juvenile, Tamarando would need to be nominated as a horse of racing age for a cost of $100,000. Hollendorfer said the cost was not an issue.

“The money is there if we wanted to do that,” he said. “We’re planning on the California-bred race. Our main goal is the CashCall Futurity.”

The Golden State Juvenile is run over a mile for California-breds. The $750,000 CashCall Futurity will be run at Betfair Hollywood Park on Dec. 14.

Lasix will not be permitted in the five Breeders’ Cup races for 2-year-olds on Nov. 1-2, a policy that ends after this year.

Tamarando was third after a slow start in the Grade 1 FrontRunner Stakes at Santa Anita on Sept. 28. By Bertrando, Tamarando has won 2 of 5 starts and earned $273,120.

Chips All In to nominate to BC

Chips All In, the winner of the Grade 3 Eddie D Stakes for turf sprinters Sept. 27, is likely to be nominated to the Breeders’ Cup for $100,000, with the intention of starting the 4-year-old in the $1 million BC Turf Sprint on Nov. 2, trainer Jeff Mullins said.

Mullins said Friday that the partnership behind Chips All In has been in discussions about paying the supplemental fee in recent weeks.

“I think the majority are with it,” he said. “When they put the money in the account, then we’ll know. I’m training him as if we’re running.”

Owned by Jean Everest, John O’Brien, Danny Valdez, and Michelle Turpin, Chips All In has won 7 of 16 starts and earned $410,613. The Eddie D Stakes, over about 6 1/2 furlongs on the hillside turf course, was the fifth stakes win for Chips All In. The BC Turf Sprint will be run over the same course.

Medication violation fines

Trainer Kristin Mulhall has been fined $1,000 after one of her starters at Santa Anita in February tested positive for carbazochrome, an anti-hemorraging medication not permitted for administration after a horse has been entered to race.

In a stipulated agreement with the California Horse Racing Board, Mulhall was suspended for seven days, but the suspension was stayed provided Mulhall does not have a similar violation in the next year.

Carbazochrome also is known as Kentucky Red. The violation was found in the post-race test taken from Hi Chooch, who finished third in a race Feb. 2.

Trainers Steve Knapp and Howard Zucker have been fined $500 each for medication violations in their runners at Del Mar over the summer.

Knapp was cited when Magic Mama, who finished ninth in an $8,000 claimer Aug. 2, tested in excess of the permitted level of the analgesic bute. Zucker was cited after Te Rapa, who won an optional claimer on turf Sept. 4, tested positive for the anti-inflammatory dexamethasone, which is not allowed to appear in post-race tests at any level.

– additional reporting by Jay Privman